What Is VIP? A Research Guide

What is VIP?

VIP is supplied by Pepology strictly for laboratory and research use only. It is not intended for use in humans or animals, and nothing in this guide describes administration, dosing, protocols or any effect in a living subject. What follows is a research-level explanation of what the molecule is and why it draws scientific interest.

VIP is short for vasoactive intestinal peptide, sometimes written as vasoactive intestinal polypeptide. It is a naturally occurring signalling peptide, meaning it belongs to the class of small proteins that cells use to pass chemical messages between one another. As a research material, it is characterised as a defined, endogenous neuropeptide rather than a synthetic novelty compound, which is part of why it is so extensively documented in the scientific literature.

At a structural level, VIP is a single-chain peptide of 28 amino acids. It sits within the secretin and glucagon peptide superfamily, a group of structurally related signalling peptides that share a broadly similar architecture and receptor style. It is derived from a larger precursor protein that is processed enzymatically to release the mature peptide. Researchers reference it alongside its close structural relative PACAP, with which it shares receptor targets. VIP is catalogued by Pepology as a defined research peptide supplied for laboratory use only.

View VIP

Why researchers study VIP

The scientific interest in VIP comes from where it sits in cell signalling. It is one of the more thoroughly mapped neuropeptides, which makes it a useful reference tool when researchers want to probe a well understood pathway rather than an obscure one. Its appeal in preclinical and laboratory research is that its receptor biology is comparatively well defined, so experiments using it as a probe can be interpreted against an existing body of literature.

VIP is described in the research literature as binding to a family of cell-surface receptors. These are most often referred to as the VPAC1 and VPAC2 receptors, which belong to the large class of G protein-coupled receptors. VIP is also associated with the closely related PAC1 receptor that it shares with PACAP. When VIP engages one of these receptors in a laboratory model, downstream second-messenger activity inside the cell is commonly studied, and this receptor-and-signalling relationship is the central object of much of the laboratory work involving the peptide.

Because these receptors appear across many tissue and cell-model systems in the published research, VIP is referenced in a wide range of preclinical contexts. It is studied as a tool for interrogating GPCR signalling, cyclic nucleotide pathways, and the behaviour of the secretin and glucagon receptor family generally. All of this framing is research interest in mechanism, not a claim of any outcome.

The receptor and signalling pathways of interest

When laboratory groups describe VIP, they usually anchor the discussion to its receptor pharmacology. The VPAC1 and VPAC2 receptors are class B G protein-coupled receptors, and their coupling behaviour is one of the reasons VIP is a recurring subject in signalling studies. Understanding how a peptide engages this receptor class, and what happens downstream, is a foundational question in receptor biology.

The pathways most commonly associated with VIP in preclinical models cluster around a few well documented themes.

• Cyclic AMP signalling, where receptor activation is studied for its role in raising intracellular second messengers in cell models.
• Neuropeptide and neurotransmission research, reflecting VIP's presence in nervous-system tissue in the wider literature.
• Smooth-muscle and vascular tone models, which is the origin of the vasoactive part of the peptide's name.
• Circadian and neuroendocrine signalling models, where VIP-expressing neurons are a recognised research subject.
• Immunological signalling studies, where VIP is examined as a modulator of cellular responses in laboratory systems.

How VIP is described at a molecular level

For anyone characterising the compound in a laboratory, a few structural facts are worth stating plainly. These are the descriptive properties researchers use to identify and confirm the material, and they are the sort of details a certificate of analysis is built to verify.

In short, VIP is best understood as a defined, endogenous neuropeptide with a documented sequence and a well studied receptor system, which is precisely what makes it a reliable reference point in mechanistic research.

• It is a peptide, so it is composed of amino acids linked in a specific chain rather than being a small-molecule chemical.
• It is 28 amino acids in length, giving it a defined and reproducible sequence that analytical methods can confirm.
• It belongs to the secretin and glucagon peptide superfamily, a structurally related group of signalling peptides.
• It is naturally occurring and derived from a larger precursor protein through enzymatic processing.
• It is structurally and functionally related to PACAP, with which it shares receptor targets in the research literature.

How to verify quality

A research peptide is only as good as the evidence that it is what the label says. Because VIP is a defined sequence, its identity and purity can be assessed with standard analytical techniques, and a reputable supplier provides that evidence rather than simply asserting it. At Pepology, every batch is third-party lab tested by Novagen Laboratories, and each batch carries a certificate of analysis that customers can verify.

A certificate of analysis is the document that reports what the testing found. Without inventing any figures, the general types of analysis that such testing covers are worth understanding, because they tell you what questions the paperwork is actually answering.

The practical point is that verification is not something you take on trust. You can match the paperwork to the physical vial and check it against an independent record.

• Identity confirmation, which uses methods such as mass spectrometry to confirm the peptide is the intended molecule and not something else.
• HPLC purity analysis, which uses high-performance liquid chromatography to characterise how much of the sample is the target peptide relative to other material.
• Lot and batch identification, so a specific certificate can be tied to a specific production run.
• A verification checklist for the buyer: confirm the certificate exists, check that the lot number on the certificate matches the lot number printed on the vial, and confirm the batch independently rather than relying on a screenshot alone.

Verify a batch certificate

Sourcing VIP in Australia with confidence

For researchers sourcing materials locally, buying within Australia removes several practical uncertainties around long international transit, customs handling and the difficulty of verifying a distant supplier. Pepology is an Australian, Gold Coast owned and operated retailer of research peptides, which means the point of contact and the accountability sit here rather than offshore.

Buying with confidence comes down to the same principles that run through this whole guide. The material should be a clearly defined compound, the batch should be third-party tested by an independent laboratory, and the certificate of analysis should be verifiable and match the vial in hand. Pepology supplies VIP on that basis: third-party lab tested by Novagen Laboratories, with a certificate you can check yourself.

As with everything in the catalogue, VIP is supplied for laboratory and research use only. It is not for human or animal use, and this article makes no claims about outcomes of any kind. If you are equipping a research setting and want a defined, verifiable peptide backed by independent testing, that is exactly what the sourcing standard here is built around.

View VIP Browse all research peptides